News Roundup: January 9 to January 13
Your weekly roundup of the latest news from Drug Topics®.
Is It Easy Being Green?
Pharmacists can make simple changes that add up to big environmental impacts.
Getting Well and Staying Well: Supporting Patient New Year’s Resolutions for 2023
Pharmacists can play an important role in patients’ wellness journeys.
FDA Grants Breakthrough Therapy Designation for VAX-24 for Invasive Pneumococcal Disease
The Breakthrough Therapy designation for VAX-24 will grant Vaxcyte access to the FDA’s Fast Track program.
Know Your Winter Respiratory Illness
With the respiratory season in full swing and COVID-19 continuing to infect, knowing the basics of the common cold, influenza, COVID-19, and respiratory syncytial virus can help ensure patients get the right care.
Top 15 Potential Blockbuster Drugs to Watch Out For
Clarivate analysts have identified the treatments they forecast could deliver annual sales of more than $1 billion within 5 years. These include therapies for rare diseases, as well as HIV, Parkinson’s disease, Crohn’s disease, alopecia, and cancer.
Driving Primary Vendor Compliance to Increase Pharmacy Purchasing Savings
April 17th 2025This white paper will examine some common—and costly—assumptions about vendor compliance. We’ll show that pharmacies must do more than meet the bare minimum to stay competitive. We’ll also discuss solutions that pharmacies can leverage to optimize compliance, drive savings from their primary vendor, unlock additional pharmacy savings and enhance purchasing.
